Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Galmed Pharmaceutica (NQ: GLMD )

0.2988 -0.0012 (-0.40%)
Streaming Delayed Price Updated: 9:30 AM EDT, Jul 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,395
Open 0.3200
Bid (Size) 0.2900 (1)
Ask (Size) 0.3200 (1)
Prev. Close 0.3000
Today's Range 0.2988 - 0.3200
52wk Range 0.2600 - 5.470
Shares Outstanding 5,045,324
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
GLMD Stock Earnings: Galmed Pharmaceuticals Reported Results for Q1 2024
Galmed Pharmaceuticals just reported results for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-32.04%
-32.04%
1 Month
-16.21%
-16.21%
3 Month
-23.13%
-23.13%
6 Month
-33.41%
-33.41%
1 Year
-88.14%
-88.14%

More News

Read More
Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024
Via InvestorPlace
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
GLMD Stock Earnings: Galmed Pharmaceuticals Misses EPS for Q4 2023
Via InvestorPlace
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
Via The Motley Fool
Gold Rises 1%; Hibbett Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nasdaq Falls Over 100 Points; Burlington Shares Jump After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Down; Chicago Fed National Activity Index Falls In October
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Nasdaq Drops 50 Points; Wells Fargo Earnings Beat Views
Via Benzinga
Crude Oil Down 2%; Citigroup Profit Tops Estimates
Via Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.